Peptide-drug-conjugates (PDCs) are being developed as an effective strategy to specifically deliver cytotoxic drugs to cancer cells. However one of the challenges to their successful application is the relativ...
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2GpKpnD
via IFTTT
No comments:
Post a Comment